Literature DB >> 34740886

Risk factors for microcystic macular oedema in glaucoma.

Golnoush Mahmoudinezhad1, Diana Salazar1, Esteban Morales1, Peter Tran1, Janet Lee2, Jean-Pierre Hubschman2, Kouros Nouri-Mahdavi1, Joseph Caprioli3.   

Abstract

BACKGROUND/AIMS: To identify clinical characteristics and factors associated with microcystic macular edema (MME) in patients with primary open-angle glaucoma (POAG).
METHODS: We included 315 POAG eyes between 2010 and 2019 with good-quality macular volume scans that had reliable visual fields (VF) available within 6 months in this observational retrospective cohort study. Eyes with retinal pathologies except for epiretinal membrane (ERM) were excluded. The inner nuclear layer was qualitatively assessed for the presence of MME. Global mean deviation (MD) and Visual Field Index (VFI) decay rates, superior and inferior MD rates and pointwise total deviation rates of change were estimated with linear regression. Logistic regression was performed to identify baseline factors associated with the presence of MME and to determine whether MME is associated with progressive VF loss.
RESULTS: 25 out of 315 eyes (7.9%) demonstrated MME. The average (±SD) age and MD in eyes with and without MME was 57.2 (±8.7) versus 62.0 (±9.9) years (p=0.02) and -9.8 (±5.7) versus -4.9 (±5.3) dB (p<0.001), respectively. Worse global MD at baseline (p=0.001) and younger age (p=0.02) were associated with presence of MME. ERM was not associated with the presence of MME (p=0.84) in this cohort. MME was not associated with MD and VFI decay rates (p>0.49).
CONCLUSIONS: More severe glaucoma and younger age were associated with MME. MME was not associated with faster global VF decay in this cohort. MME may confound monitoring of glaucoma with full macular thickness. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  glaucoma; imaging; macula

Year:  2021        PMID: 34740886      PMCID: PMC9068828          DOI: 10.1136/bjophthalmol-2021-320137

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   5.908


  27 in total

1.  Frequency of Testing to Detect Visual Field Progression Derived Using a Longitudinal Cohort of Glaucoma Patients.

Authors:  Zhichao Wu; Luke J Saunders; Fábio B Daga; Alberto Diniz-Filho; Felipe A Medeiros
Journal:  Ophthalmology       Date:  2017-03-06       Impact factor: 12.079

2.  Microcystic macular oedema in multiple sclerosis is associated with disease severity.

Authors:  Jeffrey M Gelfand; Rachel Nolan; Daniel M Schwartz; Jennifer Graves; Ari J Green
Journal:  Brain       Date:  2012-04-25       Impact factor: 13.501

3.  Microcystic macular degeneration from optic neuropathy: not inflammatory, not trans-synaptic degeneration.

Authors:  Piero Barboni; Valerio Carelli; Giacomo Savini; Michele Carbonelli; Chiara La Morgia; Alfredo A Sadun
Journal:  Brain       Date:  2013-02-08       Impact factor: 13.501

4.  Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey.

Authors:  J M Tielsch; A Sommer; J Katz; R M Royall; H A Quigley; J Javitt
Journal:  JAMA       Date:  1991-07-17       Impact factor: 56.272

5.  The clinical spectrum of microcystic macular edema.

Authors:  Marloes C Burggraaff; Jennifer Trieu; Willemien A E J de Vries-Knoppert; Lisanne Balk; Axel Petzold
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-18       Impact factor: 4.799

6.  Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study.

Authors:  Shiv Saidha; Elias S Sotirchos; Mohamed A Ibrahim; Ciprian M Crainiceanu; Jeffrey M Gelfand; Yasir J Sepah; John N Ratchford; Jiwon Oh; Michaela A Seigo; Scott D Newsome; Laura J Balcer; Elliot M Frohman; Ari J Green; Quan D Nguyen; Peter A Calabresi
Journal:  Lancet Neurol       Date:  2012-10-04       Impact factor: 44.182

7.  Microcystoid Macular Changes in Association With Idiopathic Epiretinal Membranes in Eyes With and Without Glaucoma: Clinical Insights.

Authors:  Andrea Govetto; Daniel Su; Matthew Farajzadeh; Alin Megerdichian; Eva Platner; Yvette Ducournau; Gianni Virgili; Jean Pierre Hubschman
Journal:  Am J Ophthalmol       Date:  2017-07-01       Impact factor: 5.258

8.  Clinical evaluation of microcystic macular edema in patients with glaucoma.

Authors:  N Murata; T Togano; D Miyamoto; S Ochiai; T Fukuchi
Journal:  Eye (Lond)       Date:  2016-08-12       Impact factor: 3.775

Review 9.  Müller cells as players in retinal degeneration and edema.

Authors:  Andreas Reichenbach; Antje Wurm; Thomas Pannicke; Ianors Iandiev; Peter Wiedemann; Andreas Bringmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-01-12       Impact factor: 3.535

10.  Optic neuritis is associated with inner nuclear layer thickening and microcystic macular edema independently of multiple sclerosis.

Authors:  Falko Kaufhold; Hanna Zimmermann; Elisa Schneider; Klemens Ruprecht; Friedemann Paul; Timm Oberwahrenbrock; Alexander U Brandt
Journal:  PLoS One       Date:  2013-08-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.